-- Preview Email Newsletter
| Public Policy Tipoffs Involving New Hampshire Newsletter for 2026-06-04 ( 24 items ) |
|
Attorney General Bonta Leads Coalition in Opposing Federal Legislation That Would Weaken State Privacy Protections (10)
SACRAMENTO, California, June 3 -- California Attorney General Rob Bonta issued the following news release:
* * *
Attorney General Bonta Leads Coalition in Opposing Federal Legislation That Would Weaken State Privacy Protections
*
Federal data privacy law should not preempt strong state privacy laws
OAKLAND -California Attorney General Rob Bonta yesterday led a coalition of 18 attorneys general and state agencies in opposing the Securing and Establishing Consumer Uniform Rights and Enforcem more PR
Attorney General Jeff Jackson Opposes Federal Bill That Would Tell Tech Companies They Have No Duty to Protect Kids Online (10)
RALEIGH, North Carolina, June 3 -- North Carolina Attorney General Jeff Jackson issued the following news release:
* * *
Attorney General Jeff Jackson Opposes Federal Bill That Would Tell Tech Companies They Have No Duty to Protect Kids Online
*
RALEIGH -A federal bill marketed as children's online safety legislation would tell tech companies they have no legal duty to protect kids, drop any requirement to verify users' ages, and override the stronger state laws already on the books.
Attor more PR
Dartmouth College: AI's Future Depends on Today's Choices (10)
HANOVER, New Hampshire, June 3 -- Dartmouth College issued the following news:
* * *
AI's Future Depends on Today's Choices
Panel discussion on The AI Doc shifts attention from hype to human impact.
Written by Harini Barath
At a moment when conversations about artificial intelligence are often dominated by predictions of superintelligence, existential risk, and technological revolution, it is crucial to deliberate on how society chooses to build, deploy, regulate, and relate to AI--and who more PR
Dartmouth College: How Fear and Social Pressure Are 'Overarming' the U.S. (10)
HANOVER, New Hampshire, June 4 (TNSjou) -- Dartmouth College issued the following news:
* * *
How Fear and Social Pressure Are 'Overarming' the U.S.
A Dartmouth study shows how to restore the social cost-benefit balance of firearms.
-
A Dartmouth study is the first to map the interplay of personal choice and social networks that has led to the United States being one of the world's most heavily armed countries, with 120 firearms for every 100 people.
The researchers describe in Science Adv more PR
Dartmouth College: Mark Reed Named Chief Health and Wellness Officer (10)
HANOVER, New Hampshire, June 4 -- Dartmouth College issued the following news:
* * *
Mark Reed Named Chief Health and Wellness Officer
The announcement comes as Dartmouth continues to expand its commitment to wellness.
-
President Sian Leah Beilock has made the promotion of health and wellness a top priority for Dartmouth from the beginning of her tenure. In October 2023, Dartmouth launched Commitment to Care, a strategic plan to support student mental health.
Now Mark Reed, the interim m more PR
Dartmouth College: Study Shows Octopuses' Impressive Ability to Navigate Space (10)
HANOVER, New Hampshire, June 4 (TNSjou) -- Dartmouth College issued the following news:
* * *
Study Shows Octopuses' Impressive Ability to Navigate Space
Researchers demonstrate invertebrates can solve a spatial problem using a mirror.
Written by Amy Olson
Octopuses are remarkably intelligent creatures, as was demonstrated by Inky the Octopus's famous escape from the National Aquarium of New Zealand through a drainpipe back to sea in 2016.
A new Dartmouth study shows octopuses can use mirr more PR
FDA Releases Draft Guidance Aimed at Streamlining Safety Studies for Cancer Biologics (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has released a draft guidance intended to streamline nonclinical safety studies for biologic and conjugated oncology products, a move the agency says could support cancer drug development while reducing unnecessary animal use. FDA said the recommendations are designed to help sponsors implement more efficient approaches to general toxicology assessments for selected oncology therapies whil more PR
Federal Reserve Bank of Boston Issues Beige Book on June 3, 2026 (10)
WASHINGTON, June 4 -- The Federal Reserve Bank of Boston issued the following Beige Book on June 3, 2026:
* * *
Summary of Economic Activity
Economic activity expanded slightly, representing an improvement from the previous report. Despite high gas prices, consumer spending excluding autos edged up, and auto sales rose moderately. Manufacturing activity increased slightly, with one firm reporting historically high demand. Nonfinancial services firms reported an uptick in revenues, activity am more PR
Goodlander-Backed Bipartisan Resolution to Rein in Trump's War of Choice in Iran Passes the House (10)
WASHINGTON, June 3 -- Rep. Maggie Goodlander, D-New Hampshire, issued the following news release:
* * *
Goodlander-Backed Bipartisan Resolution to Rein in Trump's War of Choice in Iran Passes the House
*
Washington, D.C. - Today, the House of Representatives passed the bipartisan Iran War Powers Resolution, a bill Congresswoman Maggie Goodlander helped lead (NH-02). It passed the House 215-208 and rebukes President Trump's unauthorized war of choice in Iran.
"We did a good thing for our Co more PR
Gov. Kelly Ayotte: New Hampshire Continues to Invest in School Safety (10)
CONCORD, New Hampshire, June 4 -- Gov. Kelly Ayotte, R-New Hampshire, issued the following proclamation on June 3, 2026:
* * *
New Hampshire Continues to Invest in School Safety
State Approves $2.6 Million for Critical Incident Mapping Program
-
Today, Governor Kelly Ayotte and the Executive Council approved a major statewide investment in school safety that will provide first responders with advanced critical incident mapping technology for public schools throughout New Hampshire to help e more PR
HHS FDA Classifies Fibromyalgia Nerve Stimulator Device Into Class II Category (10)
WASHINGTON, June 2 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying a transcutaneous electrical nerve stimulator designed to treat fibromyalgia symptoms into the agency's class II medical device category with special controls, a move the agency said will provide reasonable assurance of safety and effectiveness while reducing regulatory burdens for manufacturers.
The order, effective May 29, 2026, codifies the classific more PR
HHS FDA Classifies Intraoral Cooling Device as Class II, Establishes Safety Controls (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying an intraoral cooling device as a Class II medical device with special controls, a move that establishes regulatory requirements for technology designed to reduce the likelihood of oral mucositis in patients undergoing treatment. The action takes effect June 1, 2026, while the classification became applicable on Oct. 14, 2022. The agency said the decisio more PR
HHS FDA Classifies Swallowable Constipation Treatment Device as Class II Medical Device (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying an orally ingested transient device for constipation as a Class II medical device subject to special controls, establishing a regulatory framework for a technology that uses an electric swallowable capsule. The action takes effect June 1, 2026, and codifies a classification that was first applied on Aug. 26, 2022. FDA said the classification provides re more PR
HHS FDA Establishes Class II Category for Sterilization Containers With Electronic Monitoring (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Administration Food and Drug Administration has issued a final order classifying rigid sterilization containers with electronic monitoring as Class II medical devices subject to special controls. The action takes effect June 1, 2026, and codifies a classification that first became applicable on June 17, 2022. FDA said the classification provides reasonable assurance of safety and effectiveness while supporting patient access t more PR
HHS FDA Establishes Class II Classification for Von Willebrand Factor Assays (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying the von Willebrand factor assay as a Class II medical device subject to special controls, creating a regulatory framework for diagnostic tests used in the evaluation and management of bleeding disorders. The action takes effect June 1, 2026, and codifies a classification that became applicable on Sept. 29, 2022. FDA said the classification provides reas more PR
HHS FDA Establishes Special Controls for Endoscopic Gastric Suturing Devices (10)
WASHINGTON, June 2 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying endoscopic suturing devices used to alter gastric anatomy for weight loss as class II medical devices, a move the agency said will provide reasonable assurance of safety and effectiveness while reducing regulatory burdens for manufacturers.
The action applies to a category of devices that use suturing to approximate gastric tissue and restrict stomach more PR
HHS FDA Finalizes International Guidance on Model-Informed Drug Development (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced the availability of a final guidance titled "M15 General Principles for Model-Informed Drug Development," establishing an internationally harmonized framework for the planning, evaluation and documentation of evidence generated through model-informed drug development. The guidance was developed through the International Council for Harmonisation of Technical Requirements for more PR
HHS FDA Issues Final Guidance on Bioequivalence Studies for Generic Drug Applications (10)
WASHINGTON, June 2 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final guidance for industry outlining recommendations for bioequivalence studies that use pharmacokinetic endpoints in support of abbreviated new drug applications, amendments and supplements. The guidance, announced in the Federal Register on May 29, 2026, is intended to help applicants meet bioequivalence requirements established under the Federal Food, Drug, and Cosmetic Ac more PR
HHS FDA Issues Final Guidance on Statistical Approaches to Bioequivalence Studies (10)
WASHINGTON, June 2 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has announced the availability of a final guidance for industry titled "Statistical Approaches to Establishing Bioequivalence," updating recommendations for sponsors and applicants conducting bioequivalence studies in support of drug development and approval applications.
The guidance applies to investigational new drug applications, new drug applications, abbreviated new drug application more PR
HHS FDA Places Oropharyngeal Electrical Stimulator in Class II Device Category (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a final order classifying the oropharyngeal electrical stimulator as a Class II medical device subject to special controls, establishing a regulatory framework for technology intended to treat swallowing dysfunction. The action takes effect June 1, 2026, while the classification became applicable on Sept. 16, 2022. FDA said the decision is intended to provide reasonable assuranc more PR
HHS FDA Updates Draft Guidance on Manufacturer Communications With Health Care Payors (10)
WASHINGTON, June 4 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has released a revised draft guidance outlining how drug and medical device manufacturers may communicate health care economic information to payors, formulary committees and similar organizations involved in coverage and reimbursement decisions. The guidance, titled "Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities--Questions and Answers, more PR
Md. A.G. Brown Opposes Federal Legislation That Would Weaken State Privacy Protections (10)
BALTIMORE, Maryland, June 4 -- Maryland Attorney General Anthony G. Brown issued the following news release:
* * *
Attorney General Brown Opposes Federal Legislation That Would Weaken State Privacy Protections
Federal Data Privacy Law Should Not Preempt Strong State Privacy Laws
-
Attorney General Anthony G. Brown joined a coalition of 18 attorneys general and state agencies in opposing the Securing and Establishing Consumer Uniform Rights and Enforcement over Data Act (SECURE Data Act), more PR
Ranking Member Shaheen Presses Secretary Rubio on Trump Administration's Total Failure to Hold Russia Accountable (10)
WASHINGTON, June 4 -- Sen. Jeanne Shaheen, D-New Hampshire, ranking member of the Senate Foreign Relations Committee, issued the following news release on June 3, 2026:
* * *
Ranking Member Shaheen Presses Secretary Rubio on Trump Administration's Total Failure to Hold Russia Accountable
Today, U.S. Senator Jeanne Shaheen (D-NH), Ranking Member of the Senate Foreign Relations Committee, pressed Secretary Rubio during a Senate Appropriations Subcommittee on State, Foreign Operations and Relate more PR
Shaheen Statement on Trump Administration's New Tariff Threat (10)
WASHINGTON, June 3 -- Sen. Jeanne Shaheen, D-New Hampshire, issued the following news release:
* * *
Shaheen Statement on Trump Administration's New Tariff Threat
*
(Washington, DC) - U.S. Senator Jeanne Shaheen (D-NH), Ranking Member of the U.S. Senate Foreign Relations Committee and a senior member of the U.S. Senate Small Business Committee, today released the following statement on the Trump Administration's latest proposal to impose tariffs of at least 10% on many of the nation's top tr more PR
|
